Revenue: The sum of all revenue fields included for a company's operating activities.
Abbott Laboratories (ABT) had Revenue of $10.63B for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
|
Revenue |
$10.63B |
$1.65B |
|
$4.70B |
|
$5.94B |
|
$8.78B |
|
$1.86B |
|
$81.00M |
|
$1.94B |
|
$1.94B |
|
$1.65B |
|
$1.65B |
|
$1.65B |
|
$1.65B |
|
$1.86B |
|
$2.66B |
|
1.74B |
|
1.75B |
|
$0.94 |
|
$0.94 |
|
| Balance Sheet Financials | |
$23.80B |
|
$10.62B |
|
$50.55B |
|
$74.36B |
|
$14.90B |
|
$12.82B |
|
$19.43B |
|
$34.33B |
|
$40.03B |
|
$9.02B |
|
$40.03B |
|
1.73B |
|
| Cash Flow Statement Financials | |
$5.69B |
|
$-1.47B |
|
$-3.54B |
|
$6.90B |
|
$7.56B |
|
$662.00M |
|
$562.00M |
|
$-2.88B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.60 |
|
-- |
|
-- |
|
0.24 |
|
0.37 |
|
55.83% |
|
17.48% |
|
17.48% |
|
-- |
|
18.24% |
|
15.48% |
|
$4.20B |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.69 |
|
1.51 |
|
59.67 |
|
4.11% |
|
18.25% |
|
2.21% |
|
3.11% |
|
$23.08 |
|
$2.40 |
|
$3.26 |
|